ArticleScientific reports2025
Long-term cardiovascular complications in COVID-19 survivors according to disease severity.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- HEART Score Distribution and Association with In-Hospital Management and Outcomes in COVID-19 Survivors Presenting with Acute Chest Pain.Journal of clinical medicine · 2026Article
- Beyond recovery: long-term cardiovascular risks after severe COVID-19 requiring intensive care.Critical care (London, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Post-sepsis syndrome is a major concern affecting sepsis survivors. COVID-19 increases the risk of long-term complications, but existing data lack detail on patient-specific factors and long-term cardiovascular complications, namely major adverse cardiovascular events (MACE). Our objective was to analyze and compare the MACE occurrence, among COVID-19 survivors, according to the severity of infection. Adults aged ≥ 18 years infected during the first waves of COVID-19 pandemic hospitalized in Strasbourg University Hospital were included. Follow-up began immediately after COVID-19 diagnosis and continued for up to 12 months. Inverse probability of treatment weighting was used to balance baseline patient characteristics between the two groups (i.e. intensive care unit patients and medical ward patients). A total of 332 patients, i.e.132 in intensive care unit (ICU) and 200 in medical ward were included in the final analysis. The ICU population experienced a significantly higher risk of MACE during the first year (HR 16.2 [5.7-45.8] p < 0.001). Smoking status, history of peripheral arterial obstructive disease, and hospitalization in ICU remained independently associated with the occurrence of MACE in multivariable analysis. Severity of COVID-19 appears as an independent risk factor for MACE at one year among intensive care unit patients compared to those hospitalized in medical ward.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.